By NOF; Wednesday, June 8, 2011

Support for Legislation to Protect Patient Access to Osteoporosis Testing

On May 26, 2011, the National Osteoporosis Foundation (NOF), along with 22 other patient, professional, health and community organizations sent a letter to Senators Snowe and Stabenow, and Representatives Burgess and Berkley, thanking them for introducing S. 1096/H.R. 2020.

Download the House letter.

Download the Senate letter.

List of organization that support the Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011:

Alliance for Aging Research
American Association of Clinical Endocrinologists
American Association of Orthopaedic Surgeons
American Bone Health
American College of Nurse Midwives
American College of Radiology
American College of Rheumatology
American Congress of Obstetricians and Gynecologists
American Medical Women’s Association
American Society for Bone and Mineral Research
Assisted Living Federation of America
Association of Reproductive Health Professionals
Association of Women's Health, Obstetric and Neonatal Nurses
Black Women’s Health Imperative
Coalition of Labor Union Women
Coalition of State Rheumatology Organizations
International Society for Clinical Densitometry
International Society of Physical and Rehabilitation Medicine
National Association of Nurse Practitioners in Women's Health
National Black Nurses Association
National Council of Women's Organizations
National Medical Association
National Osteoporosis Foundation
North American Menopause Society
Older Women’s League
Osteogenesis Imperfecta Foundation
RetireSafe
Society for Women's Health Research
The Endocrine Society
The Paget Foundation
US Bone and Join Initiative
Women In Government
Women's Research & Education Institute

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.